Search Results - "Gao, Zhengzhen"
-
1
A phase I study investigation of metabolism, and disposition of [14C]-anlotinib after an oral administration in patients with advanced refractory solid tumors
Published in Cancer chemotherapy and pharmacology (01-05-2020)“…Purpose Anlotinib is a novel oral multi-targeted receptor tyrosine kinase inhibitor, which selectively inhibits VEGFR2/3, FGFR1-4, PDGFR α/β, c-kit, and Ret…”
Get full text
Journal Article -
2
Analysis of Bioactive Saponins in Fructus Gleditsiae abnormalis and Fructus Gleditsiae sinensis by LC-ELSD
Published in Chromatographia (01-11-2009)“…Fructus Gleditsiae abnormalis and Fructus Gleditsiae sinensis are widely used in traditional Chinese medicine. As different developmental stages of fruits of…”
Get full text
Journal Article -
3
Metabolic disposition of [14C]‐abivertinib, an epidermal growth factor receptor tyrosine kinase inhibitor: Role of glutathione conjugation
Published in British journal of clinical pharmacology (01-03-2021)“…Aims To determine the absorption, distribution, metabolism and excretion of abivertinib, a third‐generation epidermal growth factor receptor tyrosine kinase…”
Get full text
Journal Article